Felix68
liked
$Novavax(NVAX.US$ new low price to new high......up
3
$GameStop(GME.US$ There is too much net outflow
Translated
1
$Novavax(NVAX.US$ flying to the moon🚀
2
$GameStop(GME.US$ Go to war
Translated
Felix68
reacted to
$Intel(INTC.US$ $Apollo Global Management(APO.US$ 'Intel Nears Deal With Apollo For $11B Ireland Partnership' - Wall Street Journal
12
Felix68
voted
$Novavax(NVAX.US$
In 2024, Novavax's development reached a new climax, and the company's stock price and business development showed impressive performance. From a $1.2 billion vaccine license agreement with Sanofi to plans to promote its JN.1 protein-based non-mRNA COVID-19 vaccine globally, Novavax has certainly taken a place in the global biotech industry. In this context, many investors may be asking: is Novavax's stock still worth buying at the current price of $8-10?
Strong market dynamics
Novavax not only soared more than 99% in the first quarter of 2024, but also announced strong financial results. All of this further strengthened the market's confidence in its business model after the company reached a major vaccine licensing agreement with Sanofi. This type of collaboration provides a continuous revenue stream, while also showing Novavax's competitiveness and brand influence in the global vaccine market.
Innovative vaccine development
Additionally, the World Health Organization (WHO) recommended Novavax's JN.1 COVID-19 vaccine, which not only recognized its technology and product effectiveness, but also opened the door to the upcoming fall vaccine market. According to the company's latest non-clinical data, JN...
In 2024, Novavax's development reached a new climax, and the company's stock price and business development showed impressive performance. From a $1.2 billion vaccine license agreement with Sanofi to plans to promote its JN.1 protein-based non-mRNA COVID-19 vaccine globally, Novavax has certainly taken a place in the global biotech industry. In this context, many investors may be asking: is Novavax's stock still worth buying at the current price of $8-10?
Strong market dynamics
Novavax not only soared more than 99% in the first quarter of 2024, but also announced strong financial results. All of this further strengthened the market's confidence in its business model after the company reached a major vaccine licensing agreement with Sanofi. This type of collaboration provides a continuous revenue stream, while also showing Novavax's competitiveness and brand influence in the global vaccine market.
Innovative vaccine development
Additionally, the World Health Organization (WHO) recommended Novavax's JN.1 COVID-19 vaccine, which not only recognized its technology and product effectiveness, but also opened the door to the upcoming fall vaccine market. According to the company's latest non-clinical data, JN...
Translated
3
2
$Meta Platforms(META.US$Oleoleol gogogo
Translated
Felix68
commented on
$Intel(INTC.US$ Intel really dead? no hope?
1
2